Medical cannabis may help children suffering from chemotherapy induced nausea as well as seizures, according to a new study published in the October edition of the medical journal Pediatrics.
To come to these conclusions, researchers performed a meta-analysis of 22 relevant medical studies with a total of 795 patients. The studies were comprised of five randomized control trials, five retrospective chart reviews, five case reports, four open-label trials, two parent surveys and one case series.
Researchers found that medical cannabis was most effective in treating chemotherapy induced nausea and that there was an increasing, but not overwhelming, amount of evidence to suggest that cannabis may also help seizures.
However, researchers did not find sufficient evidence to support claims that medical cannabis helps treat spasticity, neuropathic pain, PTSD or Tourette syndrome. Noting the limitations of the study, such as small sample groups and differing cannabinoid compositions, researchers are calling for additional study of the issue.
Despite the limitations, cannabis advocates such as NORML Deputy Director Paul Armentano have hailed the study as further proof of the effectiveness of medical cannabis.
“The real-world results of these programs indicate that cannabinoids can play a role in pediatric care, particularly in the treatment of life-threatening seizures, and that they can do so in a manner that is sometimes safer and more effective than conventional treatments,” Armentano told Healthline.